Physician profile
Stephen C Hung
NPI 1073589461
$919.21
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.82 · 2020: $26.32 · 2021: $17.53 · 2022: $96.10 · 2023: $734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $108.87 | 2022-2023 | |
| Novo Nordisk INC | $97.45 | 2021-2023 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.88 | 2023 | Jardiance, Synjardy, Tradjenta |
| Lilly USA, LLC | $85.13 | 2020-2023 | Jardiance, Mounjaro |
| Otsuka America Pharmaceutical, INC. | $81.79 | 2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $78.66 | 2022-2023 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.87 | 2023 | Xifaxan |
| Glaxosmithkline, LLC. | $64.57 | 2023 | Shingrix, Arexvy |
| Amgen INC. | $51.23 | 2023 | Otezla, Repatha, Evenity |
| Pfizer INC. | $30.06 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.37 | 2022 | |
| Astellas Pharma US INC | $24.12 | 2023 | Veozah |
| Exact Sciences Corporation | $23.81 | 2023 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $23.44 | 2023 | Quviviq |
| Sobi, INC | $23.29 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.76 | 2019 | |
| Lucid Diagnostics INC. | $13.50 | 2023 | |
| Astrazeneca Pharmaceuticals Lp | $12.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Hung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.